Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity.
Neuroprotective effects of resident microglia following acute brain injury.
The quality of reports of randomized trials in multiple sclerosis: a review.
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
MS clinical trials: what can subgroup analyses teach us?
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Use of fumaric acid esters in psoriasis.
Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Assessment and Imaging of the Cerebrovascular Glycocalyx.
Microglia in health and disease.
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
…
next ›
last »